ENDRA LIFE SCIENCES INC. Share-based Compensation Arrangements by Share-based Payment Award, Options, Exercises in Period, Weighted Average Exercise Price
ENDRA LIFE SCIENCES INC. (NDRA) reported Share-based Compensation Arrangements by Share-based Payment Award, Options, Exercises in Period, Weighted Average Exercise Price of $0.00 per share for the 6-month period ending 2025-06-30, per its 10-Q filed 2025-08-14.
Financial Statements › Notes › Compensation Related Costs › Share-Based Payment Arrangement, Disclosure
us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice · last filed 2025-08-14
- ENDRA LIFE SCIENCES INC. share-based compensation arrangements by share-based payment award, options, exercises in period, weighted average exercise price for the quarter ending 2025-03-31 was $0.00.
- ENDRA LIFE SCIENCES INC. share-based compensation arrangements by share-based payment award, options, exercises in period, weighted average exercise price for the quarter ending 2024-03-31 was $0.00.
- ENDRA LIFE SCIENCES INC. share-based compensation arrangements by share-based payment award, options, exercises in period, weighted average exercise price for the quarter ending 2023-03-31 was $0.00.
- ENDRA LIFE SCIENCES INC. share-based compensation arrangements by share-based payment award, options, exercises in period, weighted average exercise price for the quarter ending 2022-03-31 was $0.00.
- ENDRA LIFE SCIENCES INC. share-based compensation arrangements by share-based payment award, options, exercises in period, weighted average exercise price for fiscal 2024 was $0.00.
- ENDRA LIFE SCIENCES INC. share-based compensation arrangements by share-based payment award, options, exercises in period, weighted average exercise price for fiscal 2023 was $0.00.
- ENDRA LIFE SCIENCES INC. share-based compensation arrangements by share-based payment award, options, exercises in period, weighted average exercise price for fiscal 2022 was $0.00.
- ENDRA LIFE SCIENCES INC. share-based compensation arrangements by share-based payment award, options, exercises in period, weighted average exercise price for fiscal 2021 was $0.00.
| Period end | Share-based Compensation Arrangements by Share-based Payment Award, Options, Exercises in Period, Weighted Average Exercise Price 3 month | Share-based Compensation Arrangements by Share-based Payment Award, Options, Exercises in Period, Weighted Average Exercise Price 6 month | Share-based Compensation Arrangements by Share-based Payment Award, Options, Exercises in Period, Weighted Average Exercise Price 9 month | Share-based Compensation Arrangements by Share-based Payment Award, Options, Exercises in Period, Weighted Average Exercise Price 12 month |
|---|---|---|---|---|
| 2025-06-30 | $0.00 10-Q · filed 2025-08-14 | |||
| 2025-03-31 | $0.00 10-Q · filed 2025-05-15 | |||
| 2024-12-31 | $0.00 10-K/A · filed 2025-04-07 | |||
| 2024-09-30 | $0.00 10-Q/A · filed 2024-11-21 | |||
| 2024-06-30 | $0.00 10-Q · filed 2024-08-14 | |||
| 2024-03-31 | $0.00 10-Q · filed 2024-05-14 | |||
| 2023-12-31 | $0.00 10-K · filed 2024-03-28 | |||
| 2023-09-30 | $0.00 10-Q · filed 2023-11-14 | |||
| 2023-06-30 | $0.00 10-Q · filed 2023-08-14 | |||
| 2023-03-31 | $0.00 10-Q · filed 2023-05-15 | |||
| 2022-12-31 | $0.00 10-K · filed 2023-03-16 | |||
| 2022-09-30 | $0.00 10-Q · filed 2022-11-14 | |||
| 2022-06-30 | $0.00 10-Q · filed 2022-08-15 | |||
| 2022-03-31 | $0.00 10-Q · filed 2022-05-12 | |||
| 2021-12-31 | $0.00 10-K · filed 2022-03-30 | |||
| 2020-12-31 | $0.00 10-K · filed 2021-03-25 | |||
| 2020-09-30 | $0.00 10-Q · filed 2020-11-16 | |||
| 2020-06-30 | $0.00 10-Q · filed 2020-08-14 | |||
| 2020-03-31 | $0.00 10-Q · filed 2020-05-14 | |||
| 2019-12-31 | $0.00 10-K · filed 2020-03-26 | |||
| 2019-09-30 | $0.00 10-Q · filed 2019-11-13 | |||
| 2019-06-30 | $0.00 10-Q · filed 2019-08-08 | |||
| 2019-03-31 | $0.00 10-Q · filed 2019-05-14 | |||
| 2018-12-31 | $0.00 10-K · filed 2019-03-11 | |||
| 2018-09-30 | $0.00 10-Q · filed 2018-11-05 | |||
| 2018-06-30 | $0.00 10-Q · filed 2018-08-13 | |||
| 2018-03-31 | $0.00 10-Q · filed 2018-05-15 | |||
| 2017-09-30 | $0.00 10-Q · filed 2017-11-14 | |||
| 2017-03-31 | $0.00 10-Q · filed 2017-06-21 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| IRIDEX CORP (IRIX) | United States | $0.011B | |
| Nuwellis, Inc. (NUWE) | United States | $0.003B | |
| QT IMAGING HOLDINGS, INC. (QTI) | United States | $0.037B | |
| PRECISION OPTICS CORPORATION, INC. (POCI) | United States | $0.052B | |
| Outset Medical, Inc. (OM) | United States | $0.059B | -1.09 |
| Streamex Corp. (STEX) | United States | $0.089B | -0.19 |
| Nexalin Technology, Inc. (NXL) | United States | $0.094B | |
| Neuraxis, INC (NRXS) | United States | $0.097B | |
| electroCore, Inc. (ECOR) | United States | $0.102B | |
| Vivani Medical, Inc. (VANI) | United States | $0.111B |